Search Results

Clinical Significance of Stent Fractures

Endovascular Today interviews Gary M. Ansel, MD

By Gary M. Ansel, MD

Ensuring Satisfaction and Quality Vascular Care as Hospitals Consolidate

Several years ago, Gary M. Ansel, MD, moved from a high-volume private practice into hospital employment, and more recently, when his hospital system began to expand, he took on the role of overseeing the entire system's vascular division. In this interview, Dr. Ansel describes physician compensation models, job satisfaction, and efforts toward establishing high-quality care, regardless of which door a patient passes through.

Primary Stenting of the Iliac Artery

Recent developments in technology have made primary stenting an attractive option.

By Gary M. Ansel, MD

An Interview With Gary Ansel, MD

A top interventional cardiologist shares his insight on the future of SFA treatment and what to expect from VIVA 2005.

By Gary Ansel, MD

One Question... What Are the Five Devices Your CLI Practice Can't Live Without?

With Sean P. Lyden, MD, FACS; Jos C. van den Berg, MD, PhD; Lawrence A. Garcia, MD, FACC, FAHA, FSCAI; Robert Lookstein, MD, FSIR, FAHA; Edward Y. Woo, MD; Mahmood Razavi, MD; Malcolm T. Foster III, MD, FACC; and John H. Rundback, MD

Tailor-Made CLI Sheaths, Catheters, and Wires

The right equipment can make all the difference in successful procedural outcomes.

By Gary M. Ansel, MD

Overcoming the Unexpected

A case report that demonstrates the unforeseen challenges and complications that can be encountered when treating thoracoabdominal aortic aneurysms.

By Marjolein J.M. Morak, MD; Sander ten Raa, MD, PhD; Frederico Bastos Goncalves, MD; and Hence J.M. Verhagen, MD, PhD

United States Regulatory Perspectives on Paclitaxel in PAD

Moderator Dr. Gary Ansel asks representatives from the FDA’s Center for Devices and Radiological Health about controlling for ascertainment and investigator bias in future vascular device trials, potential changes for drug-based device approvals, how the agency weighs the level of data required for approval of new vascular devices, the statistical strength of the data from general use studies, and the level of data needed to update FDA’s position on paclitaxel-containing devices.

With Eleni Whatley, PhD; Misti Malone, PhD; Sara Royce, PhD; and Kenneth Cavanaugh, PhD

Superficial Femoral Artery: The Forces Driving Care

By Gary M. Ansel, MD, FACC, and Koen Deloose, MD

Peripheral Vascular Care: A Clinical and Administrative Perspective

Michael R. Jaff, DO, answers questions posed by Gary M. Ansel, MD, FACC, and Koen Deloose, MD, on the challenges of his new role as hospital president and how new regulatory and reimbursement models might affect vascular care delivery.

With Michael R. Jaff, DO; Gary M. Ansel, MD, FACC; and Koen Deloose, MD

The Role of Intravascular Ultrasound in the Endovascular Treatment of Femoropopliteal Artery Lesions

How IVUS can be used to collect and analyze data on vessel and lesion characteristics to influence the success of femoropopliteal treatment.

By Osamu Iida, MD; Yosuke Hata, MD; and Naoya Kurata, BHS

One Question… How Will You Apply Drug-eluting Stents in Your SFA Practice?

Featuring Gary M. Ansel, MD; Bruce H. Gray, DO, MSVM, FSCAI; John H. Rundback, MD; and Evan Lipsitz, MD

Mechanical Devices and Acute Limb Ischemia

This increasingly common disorder responds well to alternative treatment approaches.

By Gary M. Ansel, MD; Charles F. Botti, Jr, MD; and Mitchell J. Silver, DO

Perspectives on Access and Closure

A multispecialty panel's insights into current challenges and recent developments.

With Gary Ansel, MD; Frank Arko, MD; J.A. Mustapha, MD; Peter Schneider, MD; and Jos C. van den Berg, MD, PhD

AAA Endografting in the Cath Lab

The requirements for this procedure remain the same wherever it is performed.

By Gary M. Ansel, MD